Publication | Closed Access

The BH3-mimetic obatoclax reduces HIF-1α levels and HIF-1 transcriptional activity and sensitizes hypoxic colon adenocarcinoma cells to 5-fluorouracil

Cancer ResearchOncologyGastrointestinal OncologyMedicineHif-1 Transcriptional ActivityColorectal CancerCell DeathCancer Cell BiologyRadiation OncologyCancer BiologyCell BiologyCell SignalingTumor Biology